#USA #New York #Aging Research #Healthspan #Academy for Health

The Academy for Health and Lifespan Research Welcomes New Scientists Driving Breakthroughs in Aging Research

The Academy for Health and Lifespan Research (AHLR) has recently announced an exciting addition to its distinguished group of researchers, welcoming 24 eminent scientists from various prestigious institutions around the world. Their groundbreaking contributions are expected to significantly enhance the Academy's mission of advancing the field of aging research. This announcement reflects the growing momentum in aging science, which spans multiple disciplines including molecular biology, clinical geroscience, and metabolism.

Among the new inductees is Professor Arne Akbar from University College London, an immunologist specializing in how immune function evolves with age, particularly examining T cell biology and the associated inflammatory processes. Additionally, Professor Uri Alon from the Weizmann Institute of Science has made a name for himself as a systems biologist, focusing on cellular aging and gene networks that dictate biological resilience.

Dr. Andrzej Bartke from Southern Illinois School of Medicine explores how growth hormone and life pace relate to aging, investigating early life interventions that could foster healthier aging processes. In parallel, Professor Heike A. Bischoff-Ferrari from the University of Basel leads a critical European trial on healthy longevity, focusing on the effects of vitamin D, omega-3 fatty acids, and physical activity among older adults.

Stanford University's Professor Anne Brunet investigates molecular aging mechanisms using various model organisms, aiming to develop a deeper understanding of lifespan regulation. Dr. Rochelle Buffenstein from the University of Illinois-Chicago is renowned for her research on naked mole-rats, focusing on their extraordinary longevity and resilience to age-related diseases. This perspective contributes uniquely to comparative biology, highlighting how certain mammals sustain their healthspan.

Moreover, Professor Haim Cohen from Bar-Ilan University is advancing our comprehension of metabolic regulation in aging, while Dr. Sara Espinoza from Cedars Sinai Medical Center focuses on enhancing functionality and resilience in older populations through translational research on frailty.

Dr. Toren Finkel of the University of Pittsburgh has made significant contributions toward understanding oxidative stress and mitochondrial health as they relate to age-associated diseases. Innovatively, Dr. David Glass from Regeneron Pharmaceuticals is at the forefront of biotechnology, developing therapies to combat muscle mass loss in aging individuals.

Another key figure is Dr. Derek Huffman from Albert Einstein College of Medicine, whose research combines metabolism with aging biology, presenting new strategies against age-related conditions. Professor Stephen Kritchevsky specializes in geriatric epidemiology and seeks to prevent disability and frailty among older adults at Wake Forest School of Medicine.

Mayo Clinic's Dr. Nathan LeBrasseur strives to improve mobility and curb muscle loss, while Dr. Dudley Lamming from the University of Wisconsin-Madison examines how dietary composition influences aging through nutrient signaling. Not to be overlooked is Dr. Morgan Levine, representing Altos Labs, who is at the forefront of using computational models to analyze biological aging across various organisms.

In the realm of dietary interventions, Professor Valter Longo of the University of Southern California is recognized for his research connecting nutrition and fasting with longevity. Together with Dr. William Mair from Harvard, who investigates the interplay between metabolic regulation and cellular aging processes, these scientists are paving the way for potential breakthroughs.

Lastly, noteworthy contributors, including Dr. Benjamin Miller from the Oklahoma Medical Research Foundation and Professor Daniel Promislow from the University of Washington, are working to elucidate the genetic underpinnings of aging and lifespan variations. Equally, Dr. Jing Qu from the Chinese Academy of Sciences focuses on molecular pathways driving age-related diseases, while Dr. Morten Scheibye-Knudsen from the University of Copenhagen examines human aging's molecular basis.

Professor John Speakman from the University of Aberdeen investigates energy metabolism's role in obesity and aging dynamics, while Dr. Dario Valenzano from the Leibniz Institute of Ageing utilizes evolutionary genomics to decipher aging's genetic architecture. Additionally, Dr. Ned Sharpless from Jupiter Bioventures, formerly the Director of the National Cancer Institute, emphasizes the interplay between cellular senescence, cancer, and aging.

Nir Barzilai, MD, the president of the Academy, expressed pride in welcoming these exceptional scientists. The collective expertise brought by these members will undoubtedly bolster the Academy's goal of improving healthspan and creating impactful changes in the field of aging research. Through collaboration and rigorous investigation, the Academy aims to enhance the quality of life for people everywhere.

Founded in 2019, the non-profit Academy for Health and Lifespan Research is dedicated to advancing aging research by uniting leading scientists, academic institutions, and industry partners. Its commitment to fostering breakthroughs in longevity research represents a step toward a healthier future for all generations.

To keep up with the latest updates, follow the Academy on X at @ahlresearch or visit their official website.